New medications are changing the way cancer is treated.
Severalare scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There’s even a “uni-drug” that may fight many forms of the disease. What’s especially striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide.
Here are some highlights from the world’s largest cancer meeting, the American Society of Clinical Oncology conference in Chicago:
Janssen Biotech’simproved survival and delayed cancer growth for 18 months when added to standard care in a study of 1,200 men with advanced . The drug is approved to treat tumors that are resistant to hormone therapy; this study tested it as an initial treatment.
The study was stopped early because men on Zytiga were living longer — 66 percent were alive after three years versus 49 percent of a comparison group not given the drug. Zytiga also delayed the time until cancer worsened — 33 months versus 15 months for the others.
Read full article: Drugs show promise in fighting breast, lung and prostate cancers – CBS News
|Read Full Article: Drugs show promise in fighting breast, lung and prostate cancers – CBS News|